MedicinoVa Inc. Files Q1 2025 10-Q Report
Ticker: MNOV · Form: 10-Q · Filed: May 13, 2025 · CIK: 1226616
Sentiment: neutral
Topics: 10-Q, quarterly-report, pharmaceuticals
TL;DR
MedicinoVa filed its Q1 2025 10-Q. Check financials.
AI Summary
MedicinoVa Inc. filed its quarterly report for the period ending March 31, 2025. The company, located at 4275 Executive Square, Suite 300, La Jolla, CA 92037, reported on its financial status and business operations. Key financial data and operational details for the first quarter of 2025 are presented in this filing.
Why It Matters
This filing provides investors and stakeholders with an update on MedicinoVa Inc.'s financial health and operational performance for the first quarter of 2025, crucial for investment decisions.
Risk Assessment
Risk Level: low — This is a routine quarterly filing providing standard financial and operational updates.
Key Numbers
- Q1 2025 — Reporting Period (The first quarter of 2025 financial results are detailed.)
Key Players & Entities
- MEDICINOVA INC (company) — Filer of the 10-Q report
- 4275 EXECUTIVE SQUARE SUITE 300 LA JOLLA CA 92037 (company) — Business and mailing address
- 20250331 (date) — End of the reporting period
- 20250513 (date) — Filing date
FAQ
What is the primary business of MedicinoVa Inc.?
MedicinoVa Inc. operates in the Pharmaceutical Preparations industry, SIC code 2834.
What is the fiscal year end for MedicinoVa Inc.?
MedicinoVa Inc.'s fiscal year ends on December 31st.
When was this 10-Q filing submitted to the SEC?
This 10-Q filing was submitted on May 13, 2025.
What is the SEC file number for MedicinoVa Inc.?
The SEC file number for MedicinoVa Inc. is 001-33185.
What is the company's primary address?
The company's business and mailing address is 4275 Executive Square, Suite 300, La Jolla, CA 92037.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on May 13, 2025 regarding MEDICINOVA INC (MNOV).